中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
1期
165-166
,共2页
头孢曲松钠%胸腺五肽%早期梅毒血清固定%临床疗效
頭孢麯鬆鈉%胸腺五肽%早期梅毒血清固定%臨床療效
두포곡송납%흉선오태%조기매독혈청고정%림상료효
Ceftriaxone sodium%Thymopentin%Early syphilis serum fixed%Clinical curative effect
目的:分析头孢曲松钠联合胸腺五肽治疗早期梅毒血清固定患者的临床效果。方法对照组患者采用水剂青霉素钠和苄星青霉素治疗,试验组患者采用头孢曲松钠联合胸腺五肽治疗,对两组患者的治疗效果和一年复发率进行分析对比。结果研究结果显示,试验组患者的治疗效果明显优于对照组(P<0.05)。对患者实施为期一年的随访发现,试验组的复发率明显低于对照组(P<0.05)。结论头孢曲松钠联合胸腺五肽治疗早期梅毒血清固定患者具有良好的临床疗效,降低复发率。
目的:分析頭孢麯鬆鈉聯閤胸腺五肽治療早期梅毒血清固定患者的臨床效果。方法對照組患者採用水劑青黴素鈉和芐星青黴素治療,試驗組患者採用頭孢麯鬆鈉聯閤胸腺五肽治療,對兩組患者的治療效果和一年複髮率進行分析對比。結果研究結果顯示,試驗組患者的治療效果明顯優于對照組(P<0.05)。對患者實施為期一年的隨訪髮現,試驗組的複髮率明顯低于對照組(P<0.05)。結論頭孢麯鬆鈉聯閤胸腺五肽治療早期梅毒血清固定患者具有良好的臨床療效,降低複髮率。
목적:분석두포곡송납연합흉선오태치료조기매독혈청고정환자적림상효과。방법대조조환자채용수제청매소납화변성청매소치료,시험조환자채용두포곡송납연합흉선오태치료,대량조환자적치료효과화일년복발솔진행분석대비。결과연구결과현시,시험조환자적치료효과명현우우대조조(P<0.05)。대환자실시위기일년적수방발현,시험조적복발솔명현저우대조조(P<0.05)。결론두포곡송납연합흉선오태치료조기매독혈청고정환자구유량호적림상료효,강저복발솔。
Objective To analysis of ceftriaxone sodium treatment combination with thymopentin on patients with early syphilis serum fixed clinical ef ect. Methods The control group were treated by penicil in sodium and water benzathine penicil in treatment, treatment group were treated by ceftriaxone sodium treatment, combined with thymopentin on the therapeutic ef ect of two groups of patients and one year recurrence rate were analyzed. Results The results showed that the curative ef ect of experimental group patients was better than control group (P <0.05). To implement one ~ year fol ow ~ up found that patients with experimental recurrence rate is lower than the control group significantly (P<0.05). Conclusion Ceftriaxone sodium treatment combination with thymopentin on patients with early syphilis serum fixed has good clinical curative ef ect, reduce recurrence rate, is worth popularization in clinical application.